Cargando…
The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases
Rheumatic inflammatory diseases include a diverse and heterogeneous group of multifaceted disorders in which clinical history and physical examination are essential to make treatment choices and for optimizing outcomes. Composite outcome measures have become very relevant in rheumatology to evaluate...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285275/ https://www.ncbi.nlm.nih.gov/pubmed/34285602 http://dx.doi.org/10.2147/OARRR.S276980 |
_version_ | 1783723526797131776 |
---|---|
author | Molina Collada, Juan Trives, Laura Castrejón, Isabel |
author_facet | Molina Collada, Juan Trives, Laura Castrejón, Isabel |
author_sort | Molina Collada, Juan |
collection | PubMed |
description | Rheumatic inflammatory diseases include a diverse and heterogeneous group of multifaceted disorders in which clinical history and physical examination are essential to make treatment choices and for optimizing outcomes. Composite outcome measures have become very relevant in rheumatology to evaluate disease activity as they capture the most important dimensions of the disease into one single measure. Most outcome measures may include disease manifestations, laboratory data, physician examination as well as the patient perspective as different outcome dimensions of the disease into a simple index. These outcome measures have proved their utility for guiding treatment in treat-to- target strategies and personalized medicine, with remission being the ultimate goal. In this narrative review, we go over the most commonly used outcome measures in rheumatoid arthritis, spondyloarthropathies, including psoriatic arthritis, and systemic lupus erythematosus to provide a practical summary for clinicians for everyday routine care. |
format | Online Article Text |
id | pubmed-8285275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82852752021-07-19 The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases Molina Collada, Juan Trives, Laura Castrejón, Isabel Open Access Rheumatol Review Rheumatic inflammatory diseases include a diverse and heterogeneous group of multifaceted disorders in which clinical history and physical examination are essential to make treatment choices and for optimizing outcomes. Composite outcome measures have become very relevant in rheumatology to evaluate disease activity as they capture the most important dimensions of the disease into one single measure. Most outcome measures may include disease manifestations, laboratory data, physician examination as well as the patient perspective as different outcome dimensions of the disease into a simple index. These outcome measures have proved their utility for guiding treatment in treat-to- target strategies and personalized medicine, with remission being the ultimate goal. In this narrative review, we go over the most commonly used outcome measures in rheumatoid arthritis, spondyloarthropathies, including psoriatic arthritis, and systemic lupus erythematosus to provide a practical summary for clinicians for everyday routine care. Dove 2021-07-12 /pmc/articles/PMC8285275/ /pubmed/34285602 http://dx.doi.org/10.2147/OARRR.S276980 Text en © 2021 Molina Collada et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Molina Collada, Juan Trives, Laura Castrejón, Isabel The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases |
title | The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases |
title_full | The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases |
title_fullStr | The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases |
title_full_unstemmed | The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases |
title_short | The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases |
title_sort | importance of outcome measures in the management of inflammatory rheumatic diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285275/ https://www.ncbi.nlm.nih.gov/pubmed/34285602 http://dx.doi.org/10.2147/OARRR.S276980 |
work_keys_str_mv | AT molinacolladajuan theimportanceofoutcomemeasuresinthemanagementofinflammatoryrheumaticdiseases AT triveslaura theimportanceofoutcomemeasuresinthemanagementofinflammatoryrheumaticdiseases AT castrejonisabel theimportanceofoutcomemeasuresinthemanagementofinflammatoryrheumaticdiseases AT molinacolladajuan importanceofoutcomemeasuresinthemanagementofinflammatoryrheumaticdiseases AT triveslaura importanceofoutcomemeasuresinthemanagementofinflammatoryrheumaticdiseases AT castrejonisabel importanceofoutcomemeasuresinthemanagementofinflammatoryrheumaticdiseases |